European Heart Journal

(ISSN: 0195-668X, 1522-9645)

Articles Available on Medscape

 
 

Table of Contents

From European Heart Journal

2018 -

  • Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology. 
  • Systemic right ventricular takotsubo cardiomyopathy. 
  • Pulsatile temporal vein caused by severe tricuspid regurgitation. 
  • Coronary lithoplasty: a novel treatment for stent underexpansion. 
  • Early recurrent mitral regurgitation due to MitraClip migration. 
  • Valve-in-valve-in-valve with the New Valve Technology allegra transcatheter heart valve system. 
  • How to save a life: the multidevice patient. 
  • Oral anticoagulant treatment in the elderly: there is still an unmet need for better individualized risk assessment. 
  • Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'. 
  • Acute occlusion of the right coronary artery: an unusual case. 
  • More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy. 
  • Cardiovascular outcomes in dialysis patients: one size does not fit all. 
  • Treatment-risk paradox in acute coronary syndromes. 
  • Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. 
  • Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: still waiting for solid evidence. 
  • Improving care at the population and individual level: lessons from SWEDEHEART. 
  • Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014. 
  • Acute prosthetic mitral valve dysfunction due to non-traumatic fracture of prosthesis. 
  • A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy: is this too good to be true? 
  • An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis. 
  • Death from stroke in Europe: if you can't measure it, you can't improve it. 
  • Catheter-based renal denervation: the next chapter begins. 
  • The Cardioband annuloplasty system: is it ready for prime time? 
  • Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults. 
  • Arterial hypertension and the turbulent ageing of the aortic valve. 
  • Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. 
  • Giant pulmonary arteriovenous malformation revealed by recurrent pregnancy loss. 
  • Modifier genes for sudden cardiac death. 
  • Unusual rapid progression of non-bacterial thrombotic endocarditis in a patient with bladder cancer despite undergoing intensification treatment with rivaroxaban for acute venous thromboembolism. 
  • Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial. 
  • Understanding what we mean by the obesity paradox. 
  • Disproving the obesity paradox-not. 
  • Blaming the PFO in patients with cryptogenic ischaemic stroke: Round 2. 
  • Coronary lesion complexity and the benefit of potent platelet inhibition after percutaneous coronary intervention. 
  • Can we remove scar and fibrosis from adult human myocardium? 
  • A case of fibrosing mediastinitis complicated by pulmonary hypertension and right-sided heart failure. 
  • Chronic pararenal aortic and iliac occlusion. 
  • A stone embedded in an intracardiac cyst. 
  • Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction. 
  • High blood pressure in coronary artery disease: when to start treating and what to target? 
  • Residual shunt diagnosed with 4D flow after reparation of post-infarct ventricular septal defect. 
  • Reconsidering aetiologies of type 2 myocardial infarction: when a classification is a simplistic approach for a complex reality. 
  • Isolated intracranial arterial hypertension. 
  • Can genetics predict risk for sudden cardiac death? The relentless search for the Holy Grail. 
  • Asleep blood pressure: a target for cardiovascular event reduction? 
  • Accuracy of 0/1-hour algorithm for diagnosis of MI in the elderly: mono-dimensional optimization of troponin cut-offs for individual confounders or precision medicine? 
  • Patent foramen ovale with an enormous right-to-left shunt: unusual reversible cause of hypoxia in carcinoid syndrome. 
  • First percutaneous COMBO therapy of tricuspid regurgitation using direct annuloplasty and staged edge-to-edge repair in a surgical-like Clover technique. 
  • Secondary tricuspid regurgitation in patients with left ventricular systolic dysfunction: cause for concern or innocent bystander? 
  • Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction. 
  • Impact of geographical origin upon the electrical and structural manifestations of the black athlete's heart. 
  • A comprehensive evaluation of the genetic architecture of sudden cardiac arrest. 
  • Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine. 
  • Intracardiac leiomyomatosis: a rare cause of syncope. 
  • Double hazard of smoking and alcohol on vascular function in adolescents. 
  • Early vascular damage from smoking and alcohol in teenage years: the ALSPAC study. 
  • Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study. 
  • Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey. 
  • Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment. 
  • Systemic microvascular dysfunction in microvascular and vasospastic angina. 
  • Ubiquitous yet unseen: microvascular endothelial dysfunction beyond the heart. 
  • A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. 
  • In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures. 
  • Ensuring safety and protecting patients from unnecessary harm. 
  • Fourth universal definition of myocardial infarction (2018). 
  • Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry. 
  • Can CT-derived FFR better inform clinical decision-making and improve outcomes in stable ischaemic heart disease? 
  • 2018 ESC/EACTS Guidelines on myocardial revascularization. 
  • Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization. 
  • The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients. 
  • Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC). 
  • Percutaneous mitral annuloplasty complements clip implantation in functional mitral regurgitation. 
  • Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. 
  • Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. 
  • Assessing the quality of evidence supporting patent foramen ovale closure over medical therapy after cryptogenic stroke. 
  • Reply to: Assessing the quality of evidence supporting patent foramen ovale closure over medical therapy after cryptogenic stroke. 
  • Initial single-pill combinations for antihypertensive treatment: greater cardiovascular mortality reduction yet still not used. 
  • Restrictive transfusion practice in cardiac surgery patients is safe, but what transfusion threshold is safe for my patient? 
  • Pharmacological therapy in adult congenital heart disease: growing need, yet limited evidence. 
  • Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. 
  • Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data. 
  • Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry. 
  • Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. 
  • Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. 
  • Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar. 
  • A dramatic acute respiratory distress and refractory cardiac arrest related to complete aortic valve embolization. 
  • Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation. 
  • Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council. 
  • Percutaneous treatment of a saccular coronary artery aneurysm using multimodal imaging and rapid prototyping. 
  • Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. 
  • Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. 
  • Flow dynamics in the false lumen in distal aorta following surgery for type A aortic dissection. 
  • PCSK9 in diabetes: sweet, bitter or sour? 
  • Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. 
  • Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension. 
  • Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging. 
  • Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study. 
  • Impact of mitral valve repair on the Pickelhaube sign. 
  • Corrigendum to: EHRA 2018 and new regulations. 
  • Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). 
  • Frank's sign: diagonal earlobe crease. 
  • Paravalvular root abscess with mycotic pseudoaneurysm. 
  • Patent foramen ovale and long-term risk of ischaemic stroke after surgery. 
  • Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history. 
  • The electrocardiogram and the phenotypic expression of hypertrophic cardiomyopathy. 
  • Disease modelling and drug discovery for hypertrophic cardiomyopathy using pluripotent stem cells: how far have we come? 
  • Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). 
  • Pulmonary artery rupture during right heart catheterization: successful endovascular treatment with Amplatzer Vascular Plug. 
  • PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor. 
  • Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications. 
  • Increasing population height and risk of incident atrial fibrillation: the Copenhagen City Heart Study. 
  • Application of net reclassification index to non-nested and point-based risk prediction models: a review. 
  • Pulsatile arterial haemodynamics in heart failure. 
  • Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? 
  • Myocardial fibrosis as a matter of cell differentiation: opportunities for new antifibrotic strategies. 
  • Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force. 
  • The natural history and surgical outcome of patients with scimitar syndrome. 
  • Yet another echocardiographic index: do we need more? 
  • CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. 
  • Management of left main disease: an update. 
  • Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine? 
  • The learning health system: trial design and participant consent in comparative effectiveness research. 
  • Endomyocardial fibrosis masquerading as metastatic colorectal tumour; myocardial tissue characterization pivotal in guiding urgent surgical management. 
  • Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis. 
  • Giant biventricular aneurysms: a novel cardiac phenotype in myotubular/centronuclear myopathy. 
  • Knowledge and application of European Society of Cardiology (ESC) Guidelines in the management of mitral regurgitation: this is not bad but we can do much better. 
  • Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study. 
  • Ratio of transmitral early filling velocity to early diastolic strain rate predicts long-term risk of cardiovascular morbidity and mortality in the general population. 
  • Mechanical circulatory support as bridge to urgent structural intervention. 
  • The future of continuing medical education: the roles of medical professional societies and the health care industry: Position paper prepared with contributions from the European Society of Cardiology Committees for Advocacy, Education and Industry Relations, Endorsed by the Board of the European Society of Cardiology. 
  • Lithoplasty-assisted transfemoral aortic valve implantation. 
  • Roadmap for cardiovascular education across the European Society of Cardiology: inspiring better knowledge and skills, now and for the future. 
  • Reduction in radiation exposure in cardiovascular computed tomography imaging: results from the Prospective Multicenter Registry on RadiaTion Dose Estimates of Cardiac CT AngIOgraphy IN Daily Practice in 2017 (PROTECTION VI). 
  • Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it? 
  • 18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice. 
 
 
www.viagra-on.com

www.steroid-pharm.com

https://medicaments-24.com